The significance of eosinophilic inflammation in COPD

The significance of eosinophilic inflammation in COPD

Bibliográfalaš dieđut
Váldodahkkit:	Cooper, C, Brusselle, G, Pascoe, S, Pavord, I
Materiálatiipa:	Journal article
Giella:	English
Almmustuhtton:	American Thoracic Society 2017

Geahča maid

Blood eosinophil levels as a biomarker in COPD
Dahkki: Brusselle, G, et al.
Almmustuhtton: (2018)

The significance of eosinophilic airway inflammation in asthma
Dahkki: Pavord, I, et al.
Almmustuhtton: (2002)

Mepolizumab for eosinophilic COPD
Dahkki: Sciurba, F, et al.
Almmustuhtton: (2018)

The association between blood eosinophils and risk and treatment outcome in COPD is not dichotomised
Dahkki: Pascoe, S, et al.
Almmustuhtton: (2018)

Blood eosinophils: a biomarker of COPD exacerbation reduction with inhaled corticosteroids
Dahkki: Siddiqui, S, et al.
Almmustuhtton: (2018)

Blood eosinophils: a biomarker of COPD exacerbation reduction with inhaled corticosteroids
Dahkki: Siddiqui SH, et al.
Almmustuhtton: (2018-11-01)

Seasonality of eosinophilic and non-eosinophilic exacerbations of COPD
Dahkki: Barker, R, et al.
Almmustuhtton: (2017)

Eosinophils in COPD: just another biomarker?
Dahkki: Bafadhel, M, et al.
Almmustuhtton: (2017)

Eosinophilic airway inflammation and exacerbations of COPD: a randomised controlled trial.
Dahkki: Siva, R, et al.
Almmustuhtton: (2007)

The peripheral blood eosinophil count as a biomarker of eosinophilic airway inflammation in patients with asthma and COPD. Experience from a single centre
Dahkki: Shrimanker, R, et al.
Almmustuhtton: (2017)

Blood eosinophil count and exacerbation risk in patients with COPD.
Dahkki: Kerkhof, M, et al.
Almmustuhtton: (2017)

Eicosanoids and Eosinophilic Inflammation of Airways in Stable COPD
Dahkki: Celejewska-Wójcik N, et al.
Almmustuhtton: (2021-05-01)

Serum T2-High Inflammation Mediators in Eosinophilic COPD
Dahkki: Andrius Januskevicius, et al.
Almmustuhtton: (2024-12-01)

COPD with Eosinophilic Inflammation is Susceptible to Particulate Air Pollution Exposure
Dahkki: Amja Manullang, et al.
Almmustuhtton: (2023-05-01)

Eosinophilic inflammation: a key player in COPD pathogenesis and progression
Dahkki: Yueh-Lun Lee, et al.
Almmustuhtton: (2024-12-01)

Blood eosinophil guided prednisolone therapy for exacerbations of COPD: a further analysis.
Dahkki: Bafadhel, M, et al.
Almmustuhtton: (2014)

Association between blood eosinophil count and risk of exacerbations in patients with COPD
Dahkki: Kerkhof, M, et al.
Almmustuhtton: (2017)

Copd in the ed: eosinophils, treatment and outcomes, data from the pre-award study
Dahkki: Russell, R, et al.
Almmustuhtton: (2016)

Assessment of inflammation in COPD: Observed cell profiles and the effects of treatment
Dahkki: Pavord, I
Almmustuhtton: (2002)

Eosinophil Inflammation and Hyperresponsiveness in the Airways as Phenotypes of COPD, and Usefulness of Inhaled Glucocorticosteroids
Dahkki: Hiroaki Kume, et al.
Almmustuhtton: (2019-07-01)

Blood Eosinophils and outcomes in severe hospitalized exacerbations of COPD
Dahkki: Bafadhel, M, et al.
Almmustuhtton: (2016)

Late breaking abstract - Dose-ranging study of mepolizumab in eosinophilic COPD
Dahkki: Pavord, I, et al.
Almmustuhtton: (2017)

Characterising non-eosinophilic COPD
Dahkki: Hambleton, K, et al.
Almmustuhtton: (2015)

Eosinophil protein in airway macrophages: a novel biomarker of eosinophilic inflammation in patients with asthma.
Dahkki: Kulkarni, N, et al.
Almmustuhtton: (2010)

Exacerbation Frequency And Eosinophil Counts Among Patients With COPD Currently Prescribed Triple Therapy
Dahkki: Benson VS, et al.
Almmustuhtton: (2019-11-01)

Eosinophilic Inflammation in COPD: Mechanisms, Diagnostic Markers, Clinical Features and Therapy Guidance
Dahkki: Aigerim Aitkazina, et al.
Almmustuhtton: (2024-05-01)

Investigating the role of the eosinophil in COPD
Dahkki: Camp, JR
Almmustuhtton: (2023)

Inflammatory profile of eosinophils in asthma-COPD overlap and eosinophilic COPD: a multi-omics study
Dahkki: Keeya Sunata, et al.
Almmustuhtton: (2024-10-01)

Do blood eosinophils strictly reflect airway inflammation in COPD? Comparison with asthmatic patients
Dahkki: Patrizia Pignatti, et al.
Almmustuhtton: (2019-07-01)

Blood eosinophils to guide inhaled maintenance therapy in a primary care COPD population
Dahkki: Helen F. Ashdown, et al.
Almmustuhtton: (2021-02-01)

Airway inflammation, airway responsiveness and cough before and after inhaled budesonide in patients with eosinophilic bronchitis.
Dahkki: Brightling, C, et al.
Almmustuhtton: (2000)

Eosinophilic phenotypes of airway disease.
Dahkki: Pavord, I
Almmustuhtton: (2013)

Eosinophils in asthma and airway hyperresponsiveness.
Dahkki: Brightling, C, et al.
Almmustuhtton: (2004)

Blood eosinophil count predicts treatment failure and hospital readmission for COPD
Dahkki: Marjan Kerkhof, et al.
Almmustuhtton: (2020-11-01)

Feno and blood eosinophils as biomarkers in predicting asthma exacerbations
Dahkki: Rastogi, S, et al.
Almmustuhtton: (2017)

Mepolizumab treatment in patients with severe eosinophilic asthma.
Dahkki: Ortega, H, et al.
Almmustuhtton: (2014)

Blood Eosinophils and Pulmonary Rehabilitation in COPD
Dahkki: Jafar Aljazeeri, et al.
Almmustuhtton: (2021-01-01)

Monitoring COPD patients: systemic and bronchial eosinophilic inflammation in a 2-year follow-up
Dahkki: Patrizia Pignatti, et al.
Almmustuhtton: (2024-05-01)

Eosinophilic bronchitis - what is it and why is it important?
Dahkki: Brightling, C, et al.
Almmustuhtton: (2000)

Sputum Il-17a levels correlate with biomarkers of non-eosinophilic inflammation in patients with asthma
Dahkki: Hynes, G, et al.
Almmustuhtton: (2017)